These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7114631)

  • 1. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
    Sorrell TC; Packham DR; Shanker S; Foldes M; Munro R
    Ann Intern Med; 1982 Sep; 97(3):344-50. PubMed ID: 7114631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteremia due to methicillin-resistant Staphylococcus aureus.
    Myers JP; Linnemann CC
    J Infect Dis; 1982 Apr; 145(4):532-6. PubMed ID: 6917874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
    Watanakunakorn C
    Ann Intern Med; 1982 Sep; 97(3):376-8. PubMed ID: 7114635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin?
    McManus AT; Mason AD; McManus WF; Pruitt BA
    Arch Surg; 1989 Dec; 124(12):1456-9. PubMed ID: 2589968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW; Barriere SL; Schaberg DR; Fekety R
    Antimicrob Agents Chemother; 1987 Apr; 31(4):527-30. PubMed ID: 3649202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
    Waldvogel FA
    J Hosp Infect; 1986 Mar; 7 Suppl A():37-46. PubMed ID: 2871096
    [No Abstract]   [Full Text] [Related]  

  • 9. The emergence of methicillin-resistant Staphylococcus aureus.
    Wenzel RP
    Ann Intern Med; 1982 Sep; 97(3):440-2. PubMed ID: 7114639
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.
    Lau WY; Teoh-Chan CH; Fan ST; Lau KF
    J Hyg (Lond); 1986 Jun; 96(3):419-23. PubMed ID: 3637200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.
    Markowitz N; Quinn EL; Saravolatz LD
    Ann Intern Med; 1992 Sep; 117(5):390-8. PubMed ID: 1503330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic approach to methicillin-resistant Staphylococcus aureus (MRSA) infections: vancomycin update.
    Gennery BA; Cooper GL
    Br J Clin Pract Suppl; 1988 Feb; 57():100-1. PubMed ID: 3140867
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
    Cantoni L; Wenger A; Glauser MP; Bille J
    J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
    [No Abstract]   [Full Text] [Related]  

  • 14. Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases.
    Sgarabotto D; Cusinato R; Narne E; Scano F; Zignol M; Gambino A; Cattelan A; Meneghetti F; Cadrobbi P
    Scand J Infect Dis; 2002; 34(2):122-6. PubMed ID: 11928842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence.
    French GL; Cheng AF; Ling JM; Mo P; Donnan S
    J Hosp Infect; 1990 Feb; 15(2):117-25. PubMed ID: 1969433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vancomycin in the treatment paradigm.
    Stevens DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF
    Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
    Levine DP; Cushing RD; Jui J; Brown WJ
    Ann Intern Med; 1982 Sep; 97(3):330-8. PubMed ID: 7114630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia.
    Naimi TS; Anderson D; O'Boyle C; Boxrud DJ; Johnson SK; Tenover FC; Lynfield R
    Clin Infect Dis; 2003 Jun; 36(12):1609-12. PubMed ID: 12802763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.